https://www.fda.gov/news-events/press-announcements/fda-approves-first-drug-treat-agitation-symptoms-associated-dementia-due-alzheimers-disease
0
0
5/11/23 at 1:00pm
Organization
FDA.gov
Author
Office of the Commissioner
41 words
0
Comments
The FDA granted supplemental approval to Rexulti (brexpiprazole) oral tablets for the treatment of agitation associated with dementia due to Alzheimer’s disease
You are the first to view
Create an account
or login to join the discussion